Bouchra Benettaib
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Histone Deacetylase Inhibitors Research, Neuroblastoma Research and Treatments
Most-Cited Works
- → Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial(2021)54 cited
- → Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols(2018)48 cited
- → ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children(2019)47 cited
- → Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents(2020)43 cited
- → Outcomes in RBC transfusion‐dependent patients with Low‐/Intermediate‐1‐risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS‐004 study(2014)31 cited
- → Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors(2021)11 cited
- → Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia(2021)8 cited
- → Upfront azacitidine (AZA) in juvenile myelomonocytic leukemia (JMML): Interim analysis of the prospective AZA-JMML-001 study.(2019)7 cited
- → A phase II clinical study of pomalidomide (CC-4047) monotherapy for children and young adults with recurrent or progressive primary brain tumors.(2019)6 cited
- → Phase II trial of oxaliplatin (OXA) combined with paclitaxel (P) as first-line chemotherapy for patients (pts) with advanced ovarian cancer (AOC): Preliminary results(2004)5 cited